Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Gram-positive bacterial cell envelope is a complex structure comprising a thick, multi-layered peptidoglycan cell wall and an inner cytoplasmic membrane (StatPearls, 2023). The cell wall provides essential mechanical strength to withstand high internal osmotic pressure and maintains the bacterium's shape, while the cytoplasmic membrane serves as a semi-permeable barrier involved in transport, biosignaling, and energy transduction (Nature Reviews Microbiology, 2015). This structural assembly is the primary site of action for many essential antibiotics. Beta-lactams and glycopeptides target the synthesis and cross-linking of peptidoglycan, leading to cell wall weakening and eventual osmotic lysis (Microbiology and Molecular Biology Reviews, 2008). Conversely, lipopeptides like daptomycin interact with the cytoplasmic membrane, causing rapid depolarization and loss of membrane potential, which results in bacterial cell death (Clinical Infectious Diseases, 2007). Because these structures are unique to bacteria or significantly different from eukaryotic counterparts, they represent highly effective therapeutic targets for treating infections caused by Gram-positive pathogens such as Staphylococcus aureus and Streptococcus pneumoniae.
Drugs targeting this complex act through several distinct mechanisms: inhibition of peptidoglycan cross-linking by binding to penicillin-binding proteins (beta-lactams), binding to the D-Ala-D-Ala terminus of peptidoglycan precursors to prevent polymerization (glycopeptides), or direct insertion into the cytoplasmic membrane leading to ion leakage and depolarization (lipopeptides) (StatPearls, 2023; Journal of Biological Chemistry, 2016).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cell wall and cytoplasmic membrane of Gram-positive bacteria.